John H. Baird
0000-0001-8291-6546
Stanford Hospital and Clinics
6 papers found
Refreshing results…
Bendamustine lymphodepletion is a well‐tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B‐cell lymphoma
Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma
Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma
CD22-Directed CAR T-Cell Therapy Induces Complete Remissions in CD19-Directed CAR-Refractory Large B-Cell Lymphoma
Missing publications? Search for publications with a matching author name.